Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atypical chemokine receptor 1 (ACKR1), widely known as the Duffy antigen, is a seven-transmembrane protein expressed on the surface of erythrocytes and vascular endothelial cells [UniProt P51677]. Unlike traditional G protein-coupled receptors, ACKR1 lacks the DRY motif required for G-protein signaling and instead functions as a scavenger or 'sink' for various CC and CXC chemokines, thereby regulating their plasma levels and bioavailability [PubMed: 25055861]. ACKR1 is critically important in infectious disease as the primary portal of entry for the malaria parasites Plasmodium vivax and Plasmodium knowlesi into red blood cells [PubMed: 21676837]. Genetic absence of ACKR1 on erythrocytes, common in West African populations, provides nearly complete resistance to P. vivax malaria but is also linked to benign ethnic neutropenia [PubMed: 17548550]. Beyond malaria, ACKR1 plays a significant role in modulating the inflammatory environment in conditions such as cancer and cardiovascular disease by influencing leukocyte recruitment and trafficking [PubMed: 25424747].
Competitive inhibition of Plasmodium vivax Duffy-binding protein (DBP) to prevent erythrocyte invasion; scavenging and buffering of circulating pro-inflammatory chemokines to modulate immune response.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atypical chemokine receptor 1 (ACKR1) (ACKR1).